T0	Interventions 10 45	alpha-7 nicotinic neurotransmission
T1	Interventions 91 150	Alpha7 nicotinic acetylcholine receptor (α7 nAChR) agonists
T2	Interventions 342 362	combined CDP-choline
T3	Interventions 412 504	with galantamine, a positive allosteric modulator (PAM) of nicotinic acetylcholine receptors
T4	Interventions 692 737	comparing galantamine/CDP-choline to placebos
T5	Interventions 861 897	received galantamine and CDP-choline
T6	Interventions 901 918	matching placebos
T7	Interventions 1503 1530	for galantamine/CDP-choline
T8	Interventions 1551 1562	for placebo
T9	Interventions 1773 1797	of α7 nAChR agonist/PAMs